We navigate you through the healthcare market.

Consultancy for medical device companies to support Market Access of innovative medical products.

Who we are

 

Healthcare Heads specializes in delivering tailored consultancy services in Reimbursement and Market Access exclusively designed for medical companies targeting the German healthcare market.

Our mastery of Market Access spans across pivotal areas encompassing Reimbursement, Economics, Evidence and External Affairs. These key focal points empower us to provide you with holistic and all-encompassing solutions.

Distinguished by an unparalleled fusion of expertise and an extensive track record within the German healthcare realm, we stand as your foremost partner in shaping Reimbursement and Market Access strategies and ensuring their seamless operational integration.

In collaboration with you, we surmount barriers that impede market entry, unlocking pathways to connect your pioneering technology with a broader spectrum of patients. Let us embark on this journey together, unraveling the full potential of your innovation.

E-Mail: info@healthcareheads.com

Phone: +49 431 800 147 0

 

Federal Health Minister Nina Warken plans to discontinue the hospital atlas. The atlas was introduced only in May 2024.

For manufacturers of innovative technologies, it is crucial to know which players are involved in the NUB process and how to submit a successful application.

The NUB procedure, according to section 6 para. 2 KHEntgG (Hospital Remuneration Act) allows hospitals to negotiate extrabudgetary reimbursement for new diagnostic and treatment methods with payers. Its primary purpose is to bridge the so-called…

For the next eight weeks you have the opportunity to receive reimbursement for your innovative therapy though the NUB application process.

The market access for innovative medical devices into the German healthcare system is a complex process: different reimbursement pathways, regulatory requirements, and numerous stakeholders pose major challenges for manufacturers.

The 2026 NUB applications process is about to start – now is the time to ensure the successful positioning and reimbursement of your innovative medical technology in the German healthcare market. To make the most of this opportunity, it is essential to…

Now is the time to start the NUB-process for 2026!

The German health ministry (BMG) presents the next step of the extensive German health care reform.

BfArM published the preliminary version of the OPS version 2026 on the 13th of August 2025.

Subscribe to the Healthcare Heads newsletter

with topics of Market Access and Reimbursement in Germany.

Don't miss any of the latest developments and be among the first to receive relevant information from the areas of market access and reimbursement in Germany.

Privacy policy
Marketing von